| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/22/2002 | US20020115069 Nucleotide sequences coding preferential polypeptide for use in diagnosis and treatment of osteoporosis, gastrointestinal disorders, hepatitis and tumors |
| 08/22/2002 | US20020115066 Detecting modulators which prevent viral infection; obtain lipid globule targeting sequence, incubate with modulator and globule, monitor adjustment in globule and binding protein activity |
| 08/22/2002 | US20020115064 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease |
| 08/22/2002 | US20020115061 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c viris |
| 08/22/2002 | US20020115058 Methods for diagnosis and treatment of diseases associated with altered expression of Pik3r1 |
| 08/22/2002 | US20020114818 DNA sequence coated onto carrier particle, DNA sequence comprising promoter operative in cells of a mammal and a protein coding region coding for determinant of hantavirus protein |
| 08/22/2002 | US20020114816 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 08/22/2002 | US20020114814 CTLA4-Cgamma4 fusion proteins |
| 08/22/2002 | US20020114811 Contacting body fluid from mammal with antibody which binds to human aspartyl (asparaginyl) beta-hydroxylase (HAAH) polypeptide under conditions sufficient to form antigen-antibody complex and detecting complex |
| 08/22/2002 | US20020114810 Diagnosis and treatment of malignant neoplasms statement as to federally sponsored research |
| 08/22/2002 | US20020114805 Methods of treating myelodysplastic syndrome with anti-TNF antibodies |
| 08/22/2002 | US20020114799 Protein-protein interactions in neurodegenerative diseases |
| 08/22/2002 | US20020114797 Composition and methods for modulating the length of telomeres |
| 08/22/2002 | US20020114792 Alpha-2-macroglobulin therapies and drug screening methods for Alzheimer's disease |
| 08/22/2002 | US20020114783 Human gene therapy for inherited or acquired proliferative ocular disease; transduction of mitotically active and inactive cells |
| 08/22/2002 | US20020114781 Interleukin antagonists for suppressing autoimmune respone via reducing number of antigen-reactive lymphocytes; treatment of rheumatic diseases |
| 08/22/2002 | US20020114775 Crosslinking agents and methods of use |
| 08/22/2002 | DE10108212A1 Fusionsprotein zur Sekretion von Wertprotein in bakterielle Überstände Fusion protein for secretion of value protein in bacterial supernatants |
| 08/22/2002 | DE10108211A1 Verwendung von Fusionsproteinen, deren N-terminaler Anteil aus einem Hirudinderivat besteht, zur Herstellung rekombinanter Proteine über Sekretion durch Hefen Use of fusion proteins whose N-terminal portion consists of a hirudin derivative for the production of recombinant proteins via secretion by yeasts |
| 08/22/2002 | DE10106295C1 Protein mit mehreren Antigen-Epitop-Sequenzen, welches immobilisiert ist Protein with multiple antigen epitope sequences, which is immobilized |
| 08/22/2002 | DE10104584A1 Medane-Gene und- Proteine Medane genes and- proteins |
| 08/22/2002 | DE10100238A1 Verfahren zur Vorhersage des Gefährdungspotentials für Karzinomerkrankungen und entzündliche Darmerkrankungen und zugehörige Tests A method for predicting the risk potential for cancer diseases and inflammatory bowel disease and related tests |
| 08/22/2002 | CA2854685A1 Optimized messenger rna |
| 08/22/2002 | CA2776701A1 T1r taste receptors and genes encoding same |
| 08/22/2002 | CA2441464A1 Novel scavenger receptor class a protein |
| 08/22/2002 | CA2440743A1 Matrix gene expression in chondrogenesis |
| 08/22/2002 | CA2439129A1 Novel cellular adhesion molecule of activated leukocyte |
| 08/22/2002 | CA2438658A1 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent |
| 08/22/2002 | CA2438515A1 Methods and compositions for inhibiting hiv-coreceptor interactions |
| 08/22/2002 | CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | CA2438219A1 Sequences involved in phenomena of tumour suppression, tumour reversion apoptosis and/or virus resistance and their use as medicines |
| 08/22/2002 | CA2438125A1 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 08/22/2002 | CA2437873A1 Neurotonin and use thereof |
| 08/22/2002 | CA2437868A1 Expression of human milk proteins in transgenic plants |
| 08/22/2002 | CA2437819A1 Feed additive compositions and methods |
| 08/22/2002 | CA2437811A1 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/22/2002 | CA2437799A1 Fusion proteins based upon somatostatin receptors |
| 08/22/2002 | CA2437583A1 Dna markers for meat tenderness |
| 08/22/2002 | CA2437576A1 Method for evaluating therapeutic efficacy |
| 08/22/2002 | CA2436889A1 Method for purifying the helicobacter adhesin-like protein a (alpa) |
| 08/22/2002 | CA2436789A1 Identification of target-specific folding sites in peptides and proteins |
| 08/22/2002 | CA2436713A1 Proteins and nucleic acids encoding same |
| 08/22/2002 | CA2436259A1 Compounds effecting neuron remodeling and assays for same |
| 08/22/2002 | CA2433843A1 Molecules for disease detection and treatment |
| 08/22/2002 | CA2433079A1 Regulatory genes suitable for use in gene expression |
| 08/22/2002 | CA2432364A1 Bax-responsive genes for drug target identification in yeast and fungi |
| 08/22/2002 | CA2432111A1 Jfy1 protein induces rapid apoptosis |
| 08/22/2002 | CA2431033A1 Crystallization of igf-1 |
| 08/22/2002 | CA2430726A1 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof |
| 08/22/2002 | CA2427741A1 Polynucleotide encoding a novel human potassium channel alpha-subunit, k+alpham1, and variants thereof |
| 08/22/2002 | CA2427112A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 08/22/2002 | CA2335410A1 A role for the tat protein of hiv-1 in suppression of viral reverse transcriptase activity during late stages of viral replication |
| 08/21/2002 | EP1233065A1 G-CSF analog compositions and methods |
| 08/21/2002 | EP1233064A1 Modified factor VIII cDNA and its use for the production of factor VIII |
| 08/21/2002 | EP1233059A1 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/21/2002 | EP1233025A1 Receptor expression cells and use thereof |
| 08/21/2002 | EP1233024A2 25466, a human transporter family member and uses therefor |
| 08/21/2002 | EP1233023A1 Transcription factor and dna thereof |
| 08/21/2002 | EP1233022A1 Acellular pertussis vaccines and methods of preparation thereof |
| 08/21/2002 | EP1232759A1 Gene transfer-mediated angiogenesis therapy |
| 08/21/2002 | EP1232396A2 Assay of isomerised and/or optically inverted proteins |
| 08/21/2002 | EP1232272A1 Transgenic plants exhibiting resistance to a broad spectrum of pathogens |
| 08/21/2002 | EP1232271A2 Methods and means for regulation of gene expression |
| 08/21/2002 | EP1232269A1 Method for purifying proteins |
| 08/21/2002 | EP1232267A2 Activation of hcv-specific t cells |
| 08/21/2002 | EP1232266A2 Polypeptides and nucleic acids encoding same |
| 08/21/2002 | EP1232265A2 G-protein coupled receptor htogh35 |
| 08/21/2002 | EP1232264A2 Human fgf-21 gene and gene expression products |
| 08/21/2002 | EP1232263A2 Polypeptides and nucleic acids encoding same |
| 08/21/2002 | EP1232262A2 Recombinant gelatin in vaccines |
| 08/21/2002 | EP1232261A2 Cloning and characterization of the cap gene promoter |
| 08/21/2002 | EP1232260A2 Polymorphisms in the human mdr-1 gene and applications thereof |
| 08/21/2002 | EP1232259A1 Human galanin family proteins and polynucleotides encoding the same |
| 08/21/2002 | EP1232258A1 Colon tumour-associated antigens |
| 08/21/2002 | EP1232257A2 Modular transport systems for molecular substances and production and use thereof |
| 08/21/2002 | EP1232247A2 Modulation of signal transduction |
| 08/21/2002 | EP1232245A1 Gene and methods for diagnosing neuropsychiatric disorders and treating such disorders |
| 08/21/2002 | EP1232186A2 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 08/21/2002 | EP1232183A2 Peptides having antiangiogenic activity |
| 08/21/2002 | EP1232182A2 Animal collagens and gelatins |
| 08/21/2002 | EP1232181A2 Recombinant gelatins |
| 08/21/2002 | EP1232180A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 08/21/2002 | EP1232179A1 15 human secreted proteins |
| 08/21/2002 | EP1232178A2 Compositions and methods for regulating tumor-associated antigen expression |
| 08/21/2002 | EP1232177A2 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 08/21/2002 | EP1232176A1 Tumour suppressor factor |
| 08/21/2002 | EP1232175A2 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof |
| 08/21/2002 | EP1232174A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 08/21/2002 | EP1232168A2 Synthetic lipid-a analogs and uses thereof |
| 08/21/2002 | EP1232159A1 Beta-amyloid peptide inhibitors |
| 08/21/2002 | EP1232157A2 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
| 08/21/2002 | EP1231943A1 Interferon gamma conjugates |
| 08/21/2002 | EP1231927A2 Nontoxic vernix compositions and method of producing |
| 08/21/2002 | EP1231835A2 Flowering time modification |
| 08/21/2002 | EP1231831A1 Stress-resistant oversized transgenic plants capable of growing in salinized soil |
| 08/21/2002 | EP1231830A1 Compositions and methods for modulation of plant cell division |
| 08/21/2002 | EP0980251B1 Tissue factor for influencing blood vessel formation |
| 08/21/2002 | EP0966478A4 Novel hedgehog-derived polypeptides |
| 08/21/2002 | EP0804456B1 Peptide nucleic acid conjugates |
| 08/21/2002 | EP0642580B1 Hepatocyte growth factor variants |